Impact of elective versus imperative indications on oncologic outcomes after open nephron-sparing surgery for the treatment of sporadic renal cell carcinomas

Annals of Surgical Oncology

Volumn 18, Issue 4, 2011, Pages 1151-1157

  Coffin, Grégoire ^a,b   Hupertan, Vincent ^a,b   Taksin, Lionel ^a,b   Vaessen, Christophe ^a,b   Chartier Kastler, Emmanuel ^a,b   Bitker, Marc Olivier ^a,b   Rouprêt, Morgan ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHRON SPARING SURGERY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; NEPHRONS; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955800642     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1457-6     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-49.
2. Antonelli A, Cozzoli A, Nicolai M, et al. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7 cm. Eur Urol. 2008;53:803-9.
3. Ljungberg B, Hanbury DC, Kuczyk MA, et al. Renal cell carcinoma guideline. Eur Urol. 2007;51:1502-10. (Pubitemid 46634775)
4. Mejean A, Hopirtean V, Bazin JP, et al. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol. 2003;170:764-7. (Pubitemid 36999550)
5. Lau WK, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000;75:1236-42.
6. Mitchell RE, Gilbert SM, Murphy AM, et al. Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology. 2006;67:260-4. (Pubitemid 43189838)
7. Pasticier G, Timsit MO, Badet L, et al. Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period. Eur Urol. 2006;49:485-90. (Pubitemid 43259557)
8. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735-40. (Pubitemid 44283660)
9. Lee CT, Katz J, Shi W, et al. Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol. 2000;163: 730-6. (Pubitemid 30091605)
10. Novick AC, Streem S, Montie JE, et al. Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. 1989. J Urol. 2002;167:878-83.
11. Pahernik S, Roos F, Hampel C, et al. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney:25 years of experience. J Urol. 2006;175:2027-31. (Pubitemid 43668591)
12. Ghavamian R, Cheville JC, Lohse CM, et al. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol. 2002;168:454-9. (Pubitemid 34793271)
13. Dash A, Vickers AJ, Schachter LR, et al. Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm. BJU Int. 2006;97:939-45.
14. Denzinger S, Ganzer R, Fink A, et al. Open partial nephrectomy for imperative and elective indications comparison of peri-operative data and long-term follow-up. Scand J Urol Nephrol. 2007;41:496-500. (Pubitemid 350207554)
15. Haferkamp A, Kurosch M, Pritsch M, et al. Prognostic factors influencing long-term survival of patients undergoing nephronsparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications. Ann Surg Oncol. 2010;17:544-51.
16. Kural AR, Demirkesen O, Onal B, et al. Outcome of nephronsparing surgery: elective versus imperative indications. Urol Int. 2003;71:190-6. (Pubitemid 36928791)
17. Sobin L, Gospodarowicz M, Wittekind C. TNM classification of malignant tumours. Urological tumours. 7th rev. New York: Wiley-Blackwell/UICC, 2009; p. 237-66.
18. Roupret M, Hopirtean V, Mejean A, et al. Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: a single center experience. J Urol. 2003;170:1752-5. (Pubitemid 37254921)
19. Peycelon M, Hupertan V, Comperat E, et al. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm. J Urol. 2009;181:35-41.
20. Patard JJ, Pantuck AJ, Crepel M, et al. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol. 2007;52:148-54. (Pubitemid 46803014)
21. Patard JJ, Shvarts O, Lam JS, et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 2004;171:2181-5. (Pubitemid 38625430)
22. Bensalah K, Crepel M, Patard JJ, Tumor size and nephronsparing surgery: does it still matter? Eur Urol. 2008;53:691-3. (Pubitemid 351273887)
23. Sutherland SE, Resnick MI, Maclennan GT, et al. Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter? J Urol. 2002;167:61-4. (Pubitemid 34024499)
24. McKiernan J, Simmons R, Katz J, et al. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002;59:816-20. (Pubitemid 34522166)
25. Bensalah K, Pantuck AJ, Rioux-Leclercq N, et al. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol. 2010;57:466-71.
26. Raz O, Mendlovic S, Shilo Y, et al. Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery. Urology. 2010;75:277-80.
27. Song C, Bang JK, Park HK, et al. Factors influencing renal function reduction after partial nephrectomy. J Urol. 2009;181: 48-54.
28. Timsit MO, Bazin JP, Thiounn N, et al. Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology. 2006;67: 923-6. (Pubitemid 43956418)
29. Neuzillet Y, Long JA, Paparel P, et al. Clamping modalities during partial nephrectomy: technical aspects and functional consequences. Review by the Comite de cancerologie de l'Association francaise d'urologie (CCAFU). Prog Urol. 2009; 19:524-9.
30. Lida S, Kondo T, Amano H, et al. Minimal effect of cold ischemia time on progression to late-stage chronic kidney disease observed long term after partial nephrectomy. Urology. 2008;72: 1083-9.
31. Joniau S, Vander Eeckt K, Srirangam SJ, et al. Outcome of nephron-sparing surgery for T1b renal cell carcinoma. BJU Int. 2009;103:1344-8.
32. Funahashi Y, Hattori R, Yamamoto T, et al. Ischemic renal damage after nephron-sparing surgery in patients with normal contralateral kidney. Eur Urol. 2009;55:209-15.
33. Rouach Y, Delongchamps NB, Patey N, et al. Suture or hemostatic agent during laparoscopic partial nephrectomy? A randomized study using a hypertensive porcine model. Urology. 2009;73:172-7.
34. Benway BM, Bhayani SB, Rogers CG, et al. Robot-assisted partial nephrectomy: an international experience. Eur Urol. 2010;57:815-20.
35. Gill IS, Colombo JR, Jr., Frank I, et al. Laparoscopic partial nephrectomy for hilar tumors. J Urol. 2005;174:850-4.